ARGX:NASDAQ
argenx SE - ADR
$972.25
arrow_upward
+1.33%(+12.76) 1D
$972.25
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 28, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
$954.76
High
$977.01
Low
$954.76
Mkt. cap
60.97B
Avg. vol.
274.15K
Volume
264.66K
P/E ratio
36.94
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$26.32
Beta
0.47
Shares outstanding
62.56M
No. of employees
2K
Open
$954.76
High
$977.01
Low
$954.76
Mkt. cap
60.97B
Avg. vol.
274.15K
Volume
264.66K
P/E ratio
36.94
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$26.32
Beta
0.47
Shares outstanding
62.56M
No. of employees
2K
News stories
From web sources and news partners
Yahoo Finance
·
4 hours ago
argenx SE (ARGX) Stock Forecasts
AD HOC NEWS
·
8 hours ago
argenx stock closes at EUR 844.60 on September 28, 2026, down 0.07 percent
AD HOC NEWS
·
21 hours ago
argenx stock at EUR 845.20 on September 25, 2026, up 1.25 percent
The Globe and Mail
·
2 days ago
Here's Exactly Why Wall Street Thinks Argenx Stock Could Soar 23% Over the Next 12 Months
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR